NVDA

200.95

+4.96%↑

AVGO.US

372.76

+2.87%↑

TSM

301.77

+1.15%↑

ORCL

280.65

-0.18%↓

ASML.US

1,051.93

-0.77%↓

NVDA

200.95

+4.96%↑

AVGO.US

372.76

+2.87%↑

TSM

301.77

+1.15%↑

ORCL

280.65

-0.18%↓

ASML.US

1,051.93

-0.77%↓

NVDA

200.95

+4.96%↑

AVGO.US

372.76

+2.87%↑

TSM

301.77

+1.15%↑

ORCL

280.65

-0.18%↓

ASML.US

1,051.93

-0.77%↓

NVDA

200.95

+4.96%↑

AVGO.US

372.76

+2.87%↑

TSM

301.77

+1.15%↑

ORCL

280.65

-0.18%↓

ASML.US

1,051.93

-0.77%↓

NVDA

200.95

+4.96%↑

AVGO.US

372.76

+2.87%↑

TSM

301.77

+1.15%↑

ORCL

280.65

-0.18%↓

ASML.US

1,051.93

-0.77%↓

Home・Akcijų sąrašas・Lesaka Technologies

Lesaka Technologies

Uždarymo kaina

4.24 0.95

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

4.04

Max

4.3

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-6.9M -29M
Pardavimai	33M 168M
Pelno marža	-17.183
Darbuotojai	3,728
EBITDA	-12M -23M

Dividendai
By Dow Jones
Kitas uždarbis	2025-11-05

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-4.9M 364M
Ankstesnė atidarymo kaina	3.29
Ankstesnė uždarymo kaina	4.24

Lesaka Technologies Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-28 23:50; UTC

Karštos akcijos

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

2025-10-28 23:25; UTC

Uždarbis

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

2025-10-28 23:18; UTC

Uždarbis

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

2025-10-28 22:20; UTC

Uždarbis

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

2025-10-28 22:13; UTC

Uždarbis

Wal-Mart de Mexico Net Profit Falls in 3Q

2025-10-28 21:38; UTC

Uždarbis

Correction to Visa Sales Jump Article

2025-10-28 21:17; UTC

Uždarbis

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

2025-10-28 21:07; UTC

Uždarbis

Visa Sales Jump as Consumers Keep Spending -- Update

2025-10-28 21:02; UTC

Uždarbis

Mondelez Tempers Outlook as Costs Rise

2025-10-28 23:51; UTC

Rinkos pokalbiai

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

2025-10-28 23:42; UTC

Rinkos pokalbiai

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

2025-10-28 23:02; UTC

Uždarbis

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

2025-10-28 23:01; UTC

Uždarbis

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

2025-10-28 22:46; UTC

Uždarbis

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

2025-10-28 22:45; UTC

Uždarbis

SK Hynix 3Q Net KRW12.6T >000660.SE

2025-10-28 22:44; UTC

Uždarbis

SK Hynix 3Q Rev KRW24.44T >000660.SE

2025-10-28 22:43; UTC

Uždarbis

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

2025-10-28 22:42; UTC

Uždarbis

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

2025-10-28 22:40; UTC

Uždarbis

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

2025-10-28 22:40; UTC

Uždarbis

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

2025-10-28 22:22; UTC

Uždarbis

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

2025-10-28 22:22; UTC

Uždarbis

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

2025-10-28 22:22; UTC

Uždarbis

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

2025-10-28 22:20; UTC

Uždarbis

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

2025-10-28 22:02; UTC

Uždarbis

Review & Preview: Earnings Extravaganza -- Barrons.com

2025-10-28 21:42; UTC

Rinkos pokalbiai

Uždarbis

Global Equities Roundup: Market Talk

2025-10-28 21:42; UTC

Rinkos pokalbiai

Uždarbis

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

2025-10-28 21:20; UTC

Uždarbis

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

2025-10-28 21:19; UTC

Uždarbis

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

2025-10-28 21:18; UTC

Uždarbis

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Akcijų palyginimas

Kainos pokytis

Lesaka Technologies Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių Lesaka Technologies akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Lesaka Technologies

Lesaka Technologies, Inc. operates as a Fintech company, provides financial services solutions and software in Southern Africa. The company operates through two divisions, B2C Consumer and B2B Merchant Division. It operates a full-service platform that offers a range of solutions, including transactional accounts, lending, insurance, cash management, card acceptance, supplier payments, software services, and bill payments, as well as payment solutions and value added services. The company also engages in the sale of POS devices, SIM cards, and other consumables; and licenses of right to use certain technology developed by the company. It provides its services to formal and informal consumers, micro-merchants, merchants, and enterprise clients. The company was formerly known as Net 1 UEPS Technologies, Inc. and changed its name to Lesaka Technologies, Inc. in May 2022. Lesaka Technologies, Inc. was incorporated in 1997 and is headquartered in Johannesburg, South Africa.